The global lateral flow assay market was surpassed at USD 12.52 billion in 2022 and is expected to hit around USD 17.00 billion by 2032, growing at a CAGR of 3.11% from 2023 to 2032.
Key Pointers
Report Coverage | Details |
Market Size in 2022 | USD 12.52 billion |
Revenue Forecast by 2032 | USD 17.00 billion |
Growth rate from 2023 to 2032 | CAGR of 3.11% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Covered | Abbott Laboratories; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Bio-Rad Laboratories, Inc.; bioMérieux SA; Quidel Corporation; Hologic, Inc.; PerkinElmer, Inc.; Merck KGaA; BD; Siemens Healthineers; Danaher Corporation; QIAGEN N.V. |
Lateral flow assays are used to detect the presence of a target component in the liquid sample without the need for expensive or specialized equipment. The rising prevalence of infectious diseases is anticipated to boost the growth of the lateral flow assay industry during the forecast period. For instance, according to WHO, about 10 million people worldwide suffered from tuberculosis in 2020.
Rapid detection of chronic diseases, especially infectious diseases, is necessary and should be accurate & affordable. It helps minimize the need for multiple patient visits and facilitates timely treatment & control of infectious disease outbreaks. The WHO has recommended prompt parasite-based diagnosis in all malaria-suspected patients before proper administration of treatment.
Thus, there is a growing need for rapid diagnostic test kits, facilitating prompt diagnosis and treatment. According to WHO, rapid diagnostic tests are capable of significantly improving the quality of diagnosis and management of infectious diseases, especially in areas with restricted access to advanced technologies.
The use of lateral flow devices also eliminates the need to wait for deciphering test results as well as aids in the optimization of timely treatment decisions, improves the efficacy of care provided, and significantly reduces diagnosis costs, especially in areas with resource-constrained settings and insufficient laboratory infrastructure. The rising trend of decentralized testing has been crucial in increasing the adoption of lateral flow devices globally. The role of these devices has also been observed in controlling major infectious diseases such as malaria and influenza.
According to WHO, rapid diagnostic tests are used in diagnosis by healthcare professionals distant from microscopy services; remote diagnosis by professionals in malaria-endemic countries; and outbreak investigation & survey of parasite prevalence. Thus, various benefits offered by lateral flow devices are among the key factors responsible for increasing the adoption of lateral flow devices globally.
Moreover, the rising prevalence of infectious diseases, including malaria, tuberculosis, HIV/AIDS, hepatitis, pneumonia, and influenza, is one of the major factors boosting the growth of the lateral flow assays industry. According to the World Malaria Report 2020, around 241 million malaria cases were reported in 2021, leading to over 627 thousand malaria-related deaths globally.
As per the data from the IDF Diabetes Atlas, there were about 537 million adults living with diabetes in 2021, and this number is anticipated to increase to 643 million by 2030. The disease is estimated to have caused 6.7 million deaths in 2021. Thus, with the rising incidence of chronic diseases, the demand for lateral flow assays is likely to increase in the coming years.
Lateral Flow Assay Market Segmentations:
By Product
By Application
By Technique
By Test Type
By End-user
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Lateral Flow Assay Market
5.1. COVID-19 Landscape: Lateral Flow Assay Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Lateral Flow Assay Market, By Product
8.1. Lateral Flow Assay Market, by Product, 2023-2032
8.1.1. Kits & Reagents
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Lateral Flow Readers
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Lateral Flow Assay Market, By Application
9.1. Lateral Flow Assay Market, by Application, 2023-2032
9.1.1. Clinical Testing
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Veterinary Diagnostics
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Food Safety & Environment Testing
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. Drug Development & Quality Testing
9.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Lateral Flow Assay Market, By Technique
10.1. Lateral Flow Assay Market, by Technique, 2023-2032
10.1.1. Sandwich Assays
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Competitive Assays
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Multiplex Detection Assays
10.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Lateral Flow Assay Market, By Test Type
11.1. Lateral Flow Assay Market, by Test Type, 2023-2032
11.1.1. Lateral Flow Immunoassay
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Nucleic Acid Lateral Flow Assay
11.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global Lateral Flow Assay Market, By End-user
12.1. Lateral Flow Assay Market, by End-user, 2023-2032
12.1.1. Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2019-2032)
12.1.2. Diagnostic Laboratories
12.1.2.1. Market Revenue and Forecast (2019-2032)
12.1.3. Home Care
12.1.3.1. Market Revenue and Forecast (2019-2032)
12.1.4. Pharmaceutical & Biotechnology Companies
12.1.4.1. Market Revenue and Forecast (2019-2032)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2019-2032)
Chapter 13. Global Lateral Flow Assay Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2019-2032)
13.1.2. Market Revenue and Forecast, by Application (2019-2032)
13.1.3. Market Revenue and Forecast, by Technique (2019-2032)
13.1.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.1.5. Market Revenue and Forecast, by End-user (2019-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.1.6.2. Market Revenue and Forecast, by Application (2019-2032)
13.1.6.3. Market Revenue and Forecast, by Technique (2019-2032)
13.1.6.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.1.7. Market Revenue and Forecast, by End-user (2019-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.1.8.2. Market Revenue and Forecast, by Application (2019-2032)
13.1.8.3. Market Revenue and Forecast, by Technique (2019-2032)
13.1.8.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.1.8.5. Market Revenue and Forecast, by End-user (2019-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.2. Market Revenue and Forecast, by Application (2019-2032)
13.2.3. Market Revenue and Forecast, by Technique (2019-2032)
13.2.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.2.5. Market Revenue and Forecast, by End-user (2019-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.6.2. Market Revenue and Forecast, by Application (2019-2032)
13.2.6.3. Market Revenue and Forecast, by Technique (2019-2032)
13.2.7. Market Revenue and Forecast, by Test Type (2019-2032)
13.2.8. Market Revenue and Forecast, by End-user (2019-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.9.2. Market Revenue and Forecast, by Application (2019-2032)
13.2.9.3. Market Revenue and Forecast, by Technique (2019-2032)
13.2.10. Market Revenue and Forecast, by Test Type (2019-2032)
13.2.11. Market Revenue and Forecast, by End-user (2019-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.12.2. Market Revenue and Forecast, by Application (2019-2032)
13.2.12.3. Market Revenue and Forecast, by Technique (2019-2032)
13.2.12.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.2.13. Market Revenue and Forecast, by End-user (2019-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.14.2. Market Revenue and Forecast, by Application (2019-2032)
13.2.14.3. Market Revenue and Forecast, by Technique (2019-2032)
13.2.14.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.2.15. Market Revenue and Forecast, by End-user (2019-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.2. Market Revenue and Forecast, by Application (2019-2032)
13.3.3. Market Revenue and Forecast, by Technique (2019-2032)
13.3.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.3.5. Market Revenue and Forecast, by End-user (2019-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.6.2. Market Revenue and Forecast, by Application (2019-2032)
13.3.6.3. Market Revenue and Forecast, by Technique (2019-2032)
13.3.6.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.3.7. Market Revenue and Forecast, by End-user (2019-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.8.2. Market Revenue and Forecast, by Application (2019-2032)
13.3.8.3. Market Revenue and Forecast, by Technique (2019-2032)
13.3.8.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.3.9. Market Revenue and Forecast, by End-user (2019-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.10.2. Market Revenue and Forecast, by Application (2019-2032)
13.3.10.3. Market Revenue and Forecast, by Technique (2019-2032)
13.3.10.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.3.10.5. Market Revenue and Forecast, by End-user (2019-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.11.2. Market Revenue and Forecast, by Application (2019-2032)
13.3.11.3. Market Revenue and Forecast, by Technique (2019-2032)
13.3.11.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.3.11.5. Market Revenue and Forecast, by End-user (2019-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.2. Market Revenue and Forecast, by Application (2019-2032)
13.4.3. Market Revenue and Forecast, by Technique (2019-2032)
13.4.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.4.5. Market Revenue and Forecast, by End-user (2019-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.6.2. Market Revenue and Forecast, by Application (2019-2032)
13.4.6.3. Market Revenue and Forecast, by Technique (2019-2032)
13.4.6.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.4.7. Market Revenue and Forecast, by End-user (2019-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.8.2. Market Revenue and Forecast, by Application (2019-2032)
13.4.8.3. Market Revenue and Forecast, by Technique (2019-2032)
13.4.8.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.4.9. Market Revenue and Forecast, by End-user (2019-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.10.2. Market Revenue and Forecast, by Application (2019-2032)
13.4.10.3. Market Revenue and Forecast, by Technique (2019-2032)
13.4.10.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.4.10.5. Market Revenue and Forecast, by End-user (2019-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.11.2. Market Revenue and Forecast, by Application (2019-2032)
13.4.11.3. Market Revenue and Forecast, by Technique (2019-2032)
13.4.11.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.4.11.5. Market Revenue and Forecast, by End-user (2019-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2019-2032)
13.5.2. Market Revenue and Forecast, by Application (2019-2032)
13.5.3. Market Revenue and Forecast, by Technique (2019-2032)
13.5.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.5.5. Market Revenue and Forecast, by End-user (2019-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.5.6.2. Market Revenue and Forecast, by Application (2019-2032)
13.5.6.3. Market Revenue and Forecast, by Technique (2019-2032)
13.5.6.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.5.7. Market Revenue and Forecast, by End-user (2019-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.5.8.2. Market Revenue and Forecast, by Application (2019-2032)
13.5.8.3. Market Revenue and Forecast, by Technique (2019-2032)
13.5.8.4. Market Revenue and Forecast, by Test Type (2019-2032)
13.5.8.5. Market Revenue and Forecast, by End-user (2019-2032)
Chapter 14. Company Profiles
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. F. Hoffmann-La Roche AG
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Bio-Rad Laboratories, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. bioMérieux SA
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Quidel Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Hologic, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. PerkinElmer, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Merck KGaA
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. BD
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms